277 related articles for article (PubMed ID: 16895977)
1. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
[TBL] [Abstract][Full Text] [Related]
2. Induction of nitric oxide production by the cytostatic macrolide apicularen A [2,4-heptadienamide, N-[(1E)-3-[(3S,5R,7R,9S)-3,4,5,6,7,8,9,10-octahydro-7,14 dihydroxy-1-oxo-5,9-epoxy-1H-2-benzoxacyclododecin-3-yl]-1 propenyl]-, (2Z,4Z)-(9CI)] and possible role of nitric oxide in apicularen A-induced apoptosis in RAW 264.7 cells.
Hong J; Yokomakura A; Nakano Y; Ban HS; Ishihara K; Ahn JW; Zee O; Ohuchi K
J Pharmacol Exp Ther; 2005 Mar; 312(3):968-77. PubMed ID: 15561798
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Na+/H+ exchangers in induction of cyclooxygenase-2 by vacuolar-type (H+)-ATPase inhibitors in RAW 264 cells.
Kamachi F; Yanai M; Ban HS; Ishihara K; Hong J; Ohuchi K; Hirasawa N
FEBS Lett; 2007 Oct; 581(24):4633-8. PubMed ID: 17825820
[TBL] [Abstract][Full Text] [Related]
4. Increased production of reactive oxygen species by the vacuolar-type (H(+))-ATPase inhibitors bafilomycin A1 and concanamycin A in RAW 264 cells.
Yokomakura A; Hong J; Ohuchi K; Oh SE; Lee JY; Mano N; Takahashi T; Hwang GW; Naganuma A
J Toxicol Sci; 2012; 37(5):1045-8. PubMed ID: 23038011
[TBL] [Abstract][Full Text] [Related]
5. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide is a mediator of the inhibitory effect of activated macrophages on production of androgen by the Leydig cell of the mouse.
Pomerantz DK; Pitelka V
Endocrinology; 1998 Mar; 139(3):922-31. PubMed ID: 9492021
[TBL] [Abstract][Full Text] [Related]
8. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages.
Lahti A; Jalonen U; Kankaanranta H; Moilanen E
Mol Pharmacol; 2003 Aug; 64(2):308-15. PubMed ID: 12869635
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of silkworm vacuolar-type ATPase activity by its inhibitor Bafilomycin A1 induces caspase-dependent apoptosis in an embryonic cell line of silkworm.
Tan XY; Wang X; Liu QS; Xie XQ; Li Y; Li BQ; Li ZQ; Xia QY; Zhao P
Arch Insect Biochem Physiol; 2018 Nov; 99(3):e21507. PubMed ID: 30246413
[TBL] [Abstract][Full Text] [Related]
10. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-alpha.
Furuke K; Burd PR; Horvath-Arcidiacono JA; Hori K; Mostowski H; Bloom ET
J Immunol; 1999 Aug; 163(3):1473-80. PubMed ID: 10415049
[TBL] [Abstract][Full Text] [Related]
11. Archazolid and apicularen: novel specific V-ATPase inhibitors.
Huss M; Sasse F; Kunze B; Jansen R; Steinmetz H; Ingenhorst G; Zeeck A; Wieczorek H
BMC Biochem; 2005 Aug; 6():13. PubMed ID: 16080788
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte-mediated macrophage apoptosis during IL-12 stimulation.
Yim JY; Yang SJ; Yim JM; Song MY; Rho HW; Yim SK; Han YH; Jeon SY; Kim HS; Yhim HY; Lee NR; Song EK; Kwak JY; Sohn MH; Yim CY
Cytokine; 2013 Oct; 64(1):62-70. PubMed ID: 23953854
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide inhibits stress-induced endothelial cell apoptosis.
DeMeester SL; Qiu Y; Buchman TG; Hotchkiss RS; Dunnigan K; Karl IE; Cobb JP
Crit Care Med; 1998 Sep; 26(9):1500-9. PubMed ID: 9751585
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis.
Srivastava RK; Sollott SJ; Khan L; Hansford R; Lakatta EG; Longo DL
Mol Cell Biol; 1999 Aug; 19(8):5659-74. PubMed ID: 10409755
[TBL] [Abstract][Full Text] [Related]
16. Mutations in subunit C of the vacuolar ATPase confer resistance to bafilomycin and identify a conserved antibiotic binding site.
Bowman BJ; Bowman EJ
J Biol Chem; 2002 Feb; 277(6):3965-72. PubMed ID: 11724795
[TBL] [Abstract][Full Text] [Related]
17. Silencing of secretory clusterin sensitizes NSCLC cells to V-ATPase inhibitors by downregulating survivin.
Kim YS; Jin HO; Hong SE; Song JY; Hwang CS; Park IC
Biochem Biophys Res Commun; 2018 Jan; 495(2):2004-2009. PubMed ID: 29253572
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
Okahashi N; Nakamura I; Jimi E; Koide M; Suda T; Nishihara T
J Bone Miner Res; 1997 Jul; 12(7):1116-23. PubMed ID: 9200012
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.
Nishihara T; Akifusa S; Koseki T; Kato S; Muro M; Hanada N
Biochem Biophys Res Commun; 1995 Jul; 212(1):255-62. PubMed ID: 7612014
[TBL] [Abstract][Full Text] [Related]
20. Biosynthetic investigations of the V-type ATPase inhibitors bafilomycin A1, B1 and concanamycin A.
Schuhmann T; Grond S
J Antibiot (Tokyo); 2004 Oct; 57(10):655-61. PubMed ID: 15638326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
